Did you know that a ‘good’ HCP analysis strategy should …
… be able to detect and document both broad-level HCPs and specific (critical) HCPs?
In this 30 minute webinar Ejvind Mortz, COO, covers how to design a strategy for:
• Detecting and documenting HCP impurities in process samples and final drug
• Making a detailed comparison of ELISA kits to choose the ELISA assay with highest coverage of your product’s HCPs
• Avoiding specific critical HCPs based on detailed knowledge about their characteristics